NCT00881803

Brief Summary

Iron overload is a life-threatening condition that can lead to liver disease, cardiac disease, diabetes and arthritis. Simultaneous supplementation with both iron and AA may place individuals with SCI at risk for iron overload as well as oxidative damage by iron-generated free radicals. Both conditions of high and low iron stores may present with common signs and symptoms. Accurate diagnosis of iron disorder should consider CRP, hematocrit, hemoglobin, serum iron, TIBC, percent saturation of iron binding capacity, serum ferritin and hepcidin. The investigators are proposing a study to determine the effect of concurrent AA and iron supplementation on iron status of individuals with SCI. The investigators goal is to identify abnormal status that may be attributed to simultaneous supplementation of iron and AA to develop future supplementation protocols in this population for optimal iron status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2009

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 15, 2009

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

May 23, 2012

Status Verified

May 1, 2012

Enrollment Period

2.5 years

First QC Date

March 25, 2009

Last Update Submit

May 21, 2012

Conditions

Keywords

Spinal Cord InjuriesAscorbic AcidVitamin CIronDietary Supplements

Outcome Measures

Primary Outcomes (1)

  • To determine iron status if supplemented with ascorbic acid (AA) and/or iron compared to supplementation with iron or AA.

    1 episode, at least 6 months after consistent ascorbic acid and/or iron supplementation

Secondary Outcomes (1)

  • Determine the prevalence of high iron status if receiving supplementation with both iron and AA compared to supplementation with iron or AA.

    1 episode, at least 6 months after consistent ascorbic acid and/or iron supplementation.

Study Arms (3)

Group 1

Ascorbic Acid Supplementation Only

Group 2

Iron Supplementation Only

Group 3

Concurrent Ascorbic Acid \& Iron Supplementation

Eligibility Criteria

Age18 Years - 90 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

US Veterans with spinal cord injuries greater than 6 months who are located near Bronx, NY

You may qualify if:

  • Male
  • years to 90 years of age
  • Medically stable
  • Chronic SCI (\>6 months post injury) without regard to the level or completeness of lesion
  • Supplementation with:
  • A standard recommended dose of 120-200 mg oral elemental iron (tablet or liquid; ferrous sulfate, fumarate or gluconate forms) for a minimum of 6 months; or
  • A standard recommended dose of 250-2,000 mg AA per day for a minimum of 6 months; or
  • Both 120-200 mg oral elemental iron AND 250-2,000 mg AA per day for a minimum of 6 months.
  • Veteran

You may not qualify if:

  • Acute cardiovascular, pulmonary or renal conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Medical Center, Bronx

The Bronx, New York, 10468, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples will be obtained for analysis.

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • William Bauman, MD

    VA Medical Center, Bronx

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2009

First Posted

April 15, 2009

Study Start

June 1, 2008

Primary Completion

December 1, 2010

Study Completion

June 1, 2011

Last Updated

May 23, 2012

Record last verified: 2012-05

Locations